Moderna

News

FDA has approved the 2026 COVID vaccine formulations, but last year's narrower recommendation stands, leaving open questions about access.

News

Strong phase 3 results for Moderna's individualised skin cancer vaccine could pave the way for a leap forward in the field.

News

After a series of regulatory twists and turns, the FDA has approved Moderna's mRNA-based influenza vaccine mFlusiva.

News

Moderna has started first-in-human testing of its mRNA vaccine against Bundibugyo Ebola virus, as the outbreak in DRC gathers pace.

News

A new EU procurement contract could give Moderna's RSV shot mResvia, which has struggled to gain traction in the market, a welcome boost.

News

At its latest R&D update, Moderna revealed a move into the pioneering in vivo CAR-T category, adding another treatment class to its R&D capabilities.